EUR 24.5
(0.41%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Cash Flow | - | 638.38 Million | 279.38 Million | 279.7 Million | 191.79 Million |
Net Income | 240.8 Million | 243.64 Million | 218.71 Million | 80.18 Million | 62.88 Million |
Depreciation & Amortization | - | 118.16 Million | 107.84 Million | 92.67 Million | 91.32 Million |
Deferred income taxes | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - |
Change in working capital | - | -225.9 Million | -297.86 Million | -203.32 Million | 18.63 Million |
Other non-cash items | -240.8 Million | 502.48 Million | 250.69 Million | 310.17 Million | 18.95 Million |
Investing Cash Flow | - | -90.34 Million | -24.62 Million | -227.41 Million | -191.69 Million |
Investments in PPE | - | -134.04 Million | -102.77 Million | -132.04 Million | -167.45 Million |
Acquisitions | - | - | - | - | -3.5 Million |
Investment purchases | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - |
Other Investing Activities | - | 43.69 Million | 78.15 Million | -95.36 Million | -20.72 Million |
Financing Cash Flow | - | -282.08 Million | 168.56 Million | 22.3 Million | -111.16 Million |
Debt repayment | - | -255.04 Million | -48.54 Million | -22.95 Million | -17.23 Million |
Dividends payments | - | -21.44 Million | -13.35 Million | -11.12 Million | -11.91 Million |
Common Stock Repurchased | - | -1.77 Million | - | -4.2 Million | - |
Common Stock Issuance | - | - | - | - | - |
Other Financing Activities | - | -3.81 Million | 230.45 Million | 60.58 Million | -116.48 Million |
Accounts receivables | - | -38.71 Million | -343.69 Million | 92.05 Million | 82.26 Million |
Accounts payables | - | - | - | - | - |
Inventory | - | -192.74 Million | 26.64 Million | -296.76 Million | -55.43 Million |
Other working capital | - | 5.54 Million | 19.18 Million | 1.38 Million | -8.19 Million |
Cash at beginning of period | 1.74 Billion | 1.51 Billion | 1.07 Billion | 990.44 Million | 1.1 Billion |
Cash at end of period | 1.74 Billion | 1.74 Billion | 1.51 Billion | 1.07 Billion | 990.44 Million |
Capital Expenditure | - | -134.04 Million | -102.77 Million | -132.04 Million | -167.45 Million |
Effect of forex changes on cash | - | -32.39 Million | 19.88 Million | 7.82 Million | -1.38 Million |
Net cash flow / Change in cash | - | 233.55 Million | 443.2 Million | 82.42 Million | -112.44 Million |
Free Cash Flow | - | 504.34 Million | 176.61 Million | 147.66 Million | 24.33 Million |
Breakdown | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2022 FY | 2023 Q1 | 2022 Q4 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 49.4 Million | 49.4 Million | 84.76 Million | 243.64 Million | 84.76 Million | 37.05 Million |
Depreciation & Amortization | - | - | 30.26 Million | 113.72 Million | 30.26 Million | 26.59 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | -31.98 Million | -225.9 Million | -31.98 Million | -80.97 Million |
Other non-cash items | -49.4 Million | -49.4 Million | 115.5 Million | 506.92 Million | 115.5 Million | 137.95 Million |
Investing Cash Flow | - | - | -5.5 Million | -90.34 Million | -5.5 Million | -39.67 Million |
Investments in PPE | - | - | -34.18 Million | -134.04 Million | -34.18 Million | -32.84 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | 28.67 Million | 43.69 Million | 28.67 Million | -6.83 Million |
Financing Cash Flow | - | - | -24.8 Million | -282.08 Million | -24.8 Million | -116.24 Million |
Debt repayment | - | - | - | -255.04 Million | - | - |
Dividends payments | - | - | -1000.00 | -21.44 Million | - | -10.72 Million |
Common Stock Repurchased | - | - | -685.5 Thousand | -1.77 Million | -685.5 Thousand | -202 Thousand |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | -24.11 Million | -3.81 Million | -24.11 Million | -105.31 Million |
Accounts receivables | - | - | -69.06 Million | -38.71 Million | -69.06 Million | 49.7 Million |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | 45.27 Million | -192.74 Million | 45.27 Million | -141.64 Million |
Other working capital | - | - | -8.2 Million | 5.54 Million | -8.2 Million | 10.97 Million |
Cash at beginning of period | - | - | - | 1.51 Billion | - | - |
Cash at end of period | - | - | 158.82 Million | 1.74 Billion | 158.82 Million | -42.04 Million |
Capital Expenditure | - | - | -34.18 Million | -134.04 Million | -34.18 Million | -32.84 Million |
Effect of forex changes on cash | - | - | -9.43 Million | -32.39 Million | -9.43 Million | -6.76 Million |
Net cash flow / Change in cash | - | - | 158.82 Million | 233.55 Million | 158.82 Million | -42.04 Million |
Free Cash Flow | - | - | 164.37 Million | 504.34 Million | 164.37 Million | 87.79 Million |
PLSR
002527
BMOB3
CRWOF
REGENCERAM
002947